IM Cannabis (IMCC) to Release Earnings on Thursday

IM Cannabis (NASDAQ:IMCC) is set to issue its quarterly earnings data before the market opens on Thursday, March 28th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter.

IM Cannabis Stock Performance

Shares of IMCC opened at $0.46 on Wednesday. The company has a quick ratio of 0.62, a current ratio of 1.01 and a debt-to-equity ratio of 0.02. IM Cannabis has a 12-month low of $0.19 and a 12-month high of $1.43. The business has a 50-day simple moving average of $0.30 and a two-hundred day simple moving average of $0.42.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Baader Bank INC lifted its holdings in IM Cannabis by 27.7% during the 1st quarter. Baader Bank INC now owns 235,000 shares of the company’s stock worth $503,000 after buying an additional 50,904 shares during the period. Jane Street Group LLC lifted its stake in shares of IM Cannabis by 628.8% in the third quarter. Jane Street Group LLC now owns 130,593 shares of the company’s stock worth $53,000 after acquiring an additional 112,673 shares during the period. Finally, Wasatch Advisors Inc. lifted its stake in shares of IM Cannabis by 712.7% in the first quarter. Wasatch Advisors Inc. now owns 3,822,027 shares of the company’s stock worth $8,099,000 after acquiring an additional 3,351,758 shares during the period. Institutional investors own 7.68% of the company’s stock.

IM Cannabis Company Profile

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands.